Retinalytics - AI Platform for Early Retinal Disease Detection
(Automated screening and grading of diabetic retinopathy, glaucoma, and retinal diseases from fundus images using advanced Vision-AI. )
(Automated screening and grading of diabetic retinopathy, glaucoma, and retinal diseases from fundus images using advanced Vision-AI. )
Retinova AI is an AI-powered retinal screening and diagnosis platform to detect and grade eye diseases such as diabetic retinopathy, glaucoma, Age-related Macular Degeneration (AMD), and other retinal abnormalities. Using advanced Vision-AI, the system extracts disease-specific features and provides real-time clinical insights to support faster and more accurate diagnosis. It enables scalable, efficient, and early detection of vision-threatening conditions across hospitals, clinics, and screening programs.
Automated Eye Disease Detection
Intelligent Grading & Severity Analysis
Real Time Processing
Clinical Decision Support
Scalable & Cloud Ready
Multi-Diseases Diagnosis (Glaucoma, Diabetic Retinopathy, AMD etc.)
Benefits
Faster Diagnosis and Early Detection
Reduces Ophthalmologist workload
Flexible for Large-scale screening like Medical Camps etc.
Scalable and Customizable
Rural and tele-ophthalmology deployment
Specifications
AI-powered Diseases Analytics and Disease Grading (ex. PDR and NPDR)
Fundus camera (both Table top and Hand held) and Image Resolution and Format (ex. JPG) agnostic
Cloud-ready and on-premise deployment
Explainable AI insights
Trained and Validated on Larger Datasets
Uses
Hospitals & eye care centers
Diagnostic labs
Tele-ophthalmology platforms
Government screening programs
Vision screening camps
Interested in Retinalytics
Retinalytics has evolved from research into a functional AI platform capable of automated retinal disease detection and grading, trained on large retinal datasets and ready for clinical pilots and hospital deployment. Built on a scalable SaaS model for hospitals and diagnostic centers, it also supports screening partnerships, tele-ophthalmology integrations, and public health programs—enabling widespread adoption and real-world impact in preventive eye care.